RNAC
NASDAQ
$8.18
Cartesian Therapeutics Inc (RNAC)
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company is headquartered in Watertown, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $34.57 (+322.62%)
Market Cap
$248M
Free Cash Flow Yield
-31.23%
Beta (5Y)
1.93
Price Chart
Valuation
Market Cap$248M
Forward P/E25.06
P/S142.69
P/B31.26
Profitability
Gross Profit (TTM)-$61M
EBITDA-$146M
Operating Margin-33973%
EPS-$5.70
Financial Health
Free Cash Flow Yield-31.23%
Growth & Risk
EPS 5Y CAGR-22.75%
Beta (5Y)1.93
Sharpe Ratio-0.13